Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/2010
10/12/2010US7811982 Compounds and methods for treating cancer
10/12/2010US7811791 nucleic acid ; for diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with IFN-L polypeptides
10/12/2010US7811610 Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
10/12/2010US7811599 Pharmaceutical combinations comprising a fungicide, a bacteriostatic sulphonamide and an antibacterial compound for topical application
10/12/2010US7811593 Pharmaceutical composition with combined active agents and methods for using the same
10/12/2010US7811573 Targetting dendritic cells, endothelial cells, and macrophages which express integrins, to induce maturation
10/12/2010US7811570 ablating a targeted non-malignant B cell, comprising administering to a human subject having an immune disease an unconjugated monoclonal antibody (LL2 antibody) which binds to a marker that is specific for a B cell
10/12/2010US7811557 treating a human suffering from stroke by administering directly at the site of stroke human CD 34+/-, Lin-cells from umbilical cord blood (UCB) or peripheral blood, separated from other mononuclear cells prior to use
10/12/2010US7811314 Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation
10/12/2010CA2480038C Substituted 4-aminocyclohexanols
10/12/2010CA2476164C Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity
10/12/2010CA2425420C Administration of resveratrol to treat inflammatory respiratory disorders
10/12/2010CA2419205C Anti-tnf antibodies, compositions, methods and uses
10/12/2010CA2416899C Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
10/12/2010CA2413699C Topical pharmaceutical formulations and methods of treatment
10/12/2010CA2411960C Analgesic and anti-inflammatory compositions containing cox-2 inhibitors
10/12/2010CA2376305C Sulfonamide and sulfamide substituted imidazoquinolines
10/12/2010CA2313089C Methods for treatment of neuro- and nephro- disorders and therapeutic toxicities using aminothiol compounds
10/12/2010CA2229590C Pharmaceutical composition containing inhibitors of interferon- gamma
10/07/2010WO2010113627A1 Highly sensitive detection method for highly virulent oral cavity bacteria
10/07/2010WO2010112578A1 4 -isopropyl-3-methylphenol for the treatment of inflammation
10/07/2010WO2010112577A1 Antibacterial composition comprising 4 -isopropyl-3-methylpheno and zinc ions
10/07/2010WO2010112530A1 Pipamperone and a second agent in treating mood and anxiety disorders
10/07/2010WO2010112497A1 Domperidone at a low daily dose for use in the treatment or prevention of a disease associated with an alteration of the immune response
10/07/2010WO2010112411A1 Co-crystal of etravirine and nicotinamide
10/07/2010WO2010112256A1 Satiety-inducing composition
10/07/2010WO2010081862A3 Methods and preparations for protecting critically ill patients with a polyamine (e.g. spermine, spermidine)
10/07/2010WO2010060939A3 Pharmaceutical combinations comprising a pyrido [4, 3-d] pyrimidine derived hsp90-inhibitor and a her2 inhibitor
10/07/2010WO2010055072A3 Treating cancer by modulating a mnk
10/07/2010WO2001079455A9 Kv10.1, A NOVEL VOLTAGE-GATED POTASSIUM CHANNEL FROM HUMAN BRAIN
10/07/2010US20100256230 1-butane acid derivatives, pharmaceutical compositions containing said derivatives and the use thereof
10/07/2010US20100256119 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
10/07/2010US20100255538 Antibodies to insulin-like growth factor i receptor
10/07/2010US20100255537 Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof
10/07/2010US20100255081 Method for treating symptoms of diabetes
10/07/2010US20100255073 Composition for transdermal delivery of fentanyl
10/07/2010US20100255009 Methods for Inducing Mixed Donor-Recipient Chimerism in an Allograft Transplant Recipient
10/07/2010US20100254999 Eg-vegf nucleic acids and polypeptides and methods of use
10/07/2010US20100254990 Anti-ngf antibodies for the treatment of various disorders
10/07/2010US20100254966 Treatment of glycogen storage disease type ii
10/07/2010US20100254940 Compositions and Methods for Regulating an Immune Response in a Subject
10/07/2010CA2757228A1 Co-crystal of etravirine and nicotinamide
10/07/2010CA2757065A1 Antibacterial composition comprising 4 -isopropyl-3-methylphenol and zinc ions
10/06/2010EP2237042A1 Marker for determination of sensitivity to anti-cancer agent
10/06/2010EP2236507A1 N-pyrazole-2-pyridinecarboxamide derivative
10/06/2010EP2236161A1 Polymer conjugates of opioid antagonists
10/06/2010EP2236158A1 New therapeutic approaches for treating neuroinflammatory conditions
10/06/2010EP2236157A1 Pipamperone and a second agent in treating mood and anxiety disorders
10/06/2010EP2236156A2 Methods for treating and diagnosing Psoriasis
10/06/2010EP2236145A1 Pharmaceutical composition and combined agent
10/06/2010EP2236138A1 Low dose pipamperone in treating mood and anxiety disorders
10/06/2010EP2236134A1 Combinations of DMXAA and other anti-cancer agents
10/06/2010EP2236131A2 Compositions for manipulating the lifespan and stress response of cells and organisms
10/06/2010EP2236106A1 Apparatus for stenting adapted for use in a bifurcated vessel comprising enhanced protection against embolism, restenosis and thrombus formation
10/06/2010EP2234963A1 Controlled release formulations of levodopa and uses thereof
10/06/2010EP2234643A2 Composition for treatment of tuberculosis
10/06/2010EP2234642A1 Method of increasing immunological effect
10/06/2010EP2234622A2 Methods for enhancing muscle performance and tone
10/06/2010EP1637132B1 External preparation for athlete´s foot treatment
10/06/2010EP1515965B1 Phenylaminopyrimidines and their use as rho-kinase inhibitors
10/06/2010EP1456650B1 Gfats as modifiers of the p53 pathway and methods of use
10/06/2010EP1352077B1 Materials and methods relating to protein aggregation in neurodegenerative disease
10/06/2010EP1220906B1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby
10/06/2010CN1857220B Slow released antituberculotic preparation
10/06/2010CN1711074B Liposomes
10/06/2010CN1681508B Novel inhibitors of kinases
10/06/2010CN1520300B Dihydro-triterpenes in treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain
10/06/2010CN1514726B Pharmaceutical compositions
10/06/2010CN101854952A Isoflavone formulation
10/06/2010CN101854932A Combination therapy comprising angiotensin converting enzyme inhibitors and vasopressin receptor antagonists
10/06/2010CN101854919A Compositions for the treatment of neoplastic diseases
10/06/2010CN101851191A Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment
10/06/2010CN101850120A Solutions and methods for inhibition of pain, inflammation and cartilage degradation
10/06/2010CN101850119A Compound preparation used for treating melancholia and senile dementia
10/06/2010CN101850108A Methods and pharmaceutical compositions for healing wounds
10/06/2010CN101849924A Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
10/06/2010CN101849911A Improvements relating to antiparasitcs
10/06/2010CN101417130B Medicine combination for treating II type diabetes and complicating diseases thereof
10/06/2010CN101391104B New use of oncolytic adenovirus recombinant of tumour cell single-expression immunoloregulation fator GM-CSF
10/06/2010CN101334356B Gas sensors
10/05/2010US7809417 Contact lens for collecting tears and detecting analytes for determining health status, ovulation detection, and diabetes screening
10/05/2010US7807814 Compositions and methods for combined therapy of disease
10/05/2010US7807803 For prophylaxis and therapy of infectious disease, allergy, cancer
10/05/2010US7807780 Multi-component biological transport systems
10/05/2010US7807778 Cysteine-containing peptide tag for site-specific conjugation of proteins
10/05/2010US7807682 Pyridyl cyanoguanidine compounds
10/05/2010US7807678 Peptidomimetics of biologically active metallopeptides
10/05/2010US7807663 Therapeutic agents for diabetes
10/05/2010US7807660 Tetracycline compounds for treatment of Cryptosporidium parvum related disorders
10/05/2010US7807657 comprising liquid (A) which is aqueous solution containing hyaluronic acid ester derivative and buffered to pH of 4.5 to 6.5, and liquid (B) which is aqueous solution having a buffering power that when mixed with liquid (A), the mixed liquid has a pH range from 6.8 to 7.8, kept separate from eachother
10/05/2010US7807463 Pretreatment of animal with antibodies to sensitize animal; controlling dosage
10/05/2010US7807384 Drug screening; identifying a candidate agent that inhibits the binding of low density lipoprotein binding protein-2 (LBP-2) to an LBP-2 binding molecule
10/05/2010US7807355 drug screening; identifying a therapeutic for decreasing intraocular pressure raised due to frizzled related protein (FRP) overexpression; contacting a trabecular meshwork cell expressing a Wnt pathway component or a frizzled related protein gene product with a test compound
10/05/2010US7807202 Mixture of tea tree oil and mineral such as selenium, iodine or silver; warts caused by the Molluscum contagiosum virus, human papillomavirus, and/or herpes simplex virus, chicken pox or shingles; does not destroy healthy, uninfected tissues, side effect reduction
10/05/2010US7807198 containing a polymer, a therapeutic agent, and a complexing agent, where the polymer interacts with the complexing agent in a host-guest or a guest-host interaction to form an inclusion complex; may be used to deliver a therapeutic agent in treatment of various disorders
10/05/2010US7807191 Apparatus and methods for preventing or treating failure of hemodialysis vascular access and other vascular grafts
10/05/2010US7807185 applying to skin or mucous membrane of a mammal a composition comprising an extracellular product of a Pseudomonas lindbergii strain, an extracellular product of a Bacillus coagulans strain, and an anti-fungal agent selected from Amphotericin B, Carbol-Fuchsin, Ciclopirox, for example
10/05/2010US7807167 using an agent that specifically binds to an alpha-4 integrin or a dimer comprising an alpha-4 integrin; treatment of multiple sclerosis or inflammatory disease of the gastrointestinal tract
10/05/2010US7807163 Antibodies against GPR64 and uses thereof
10/05/2010US7807151 identifying a mammalian subject having an infection with said pathogenic Clostridium bacterium resistant to antibiotic, orally administering a therapeutically-effective concentration of Bacillus coagulans bacteria
1 ... 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 ... 1151